| scholarly article | Q13442814 |
| P50 | author | Bruce M. Psaty | Q30429993 |
| Susan R Heckbert | Q88077554 | ||
| P2093 | author name string | Nicholas L Smith | |
| Kenneth Rice | |||
| Robert C Kaplan | |||
| Stanley Zucker | |||
| P2860 | cites work | A New Statistical Method for Haplotype Reconstruction from Population Data | Q27860495 |
| Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms | Q28137791 | ||
| Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression | Q28281614 | ||
| Simple estimates of haplotype relative risks in case-control data | Q31043466 | ||
| Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Use of alendronate and risk of incident atrial fibrillation in women | Q34774594 | ||
| Matrix metalloproteinases in neuroinflammation | Q34803809 | ||
| Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. | Q38464070 | ||
| Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension | Q38489772 | ||
| Identification of genetic factors and development of genetic risk diagnosis systems for cardiovascular diseases and stroke | Q40285475 | ||
| TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase | Q41093803 | ||
| Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. | Q42602106 | ||
| The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina | Q44121488 | ||
| Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury | Q46185703 | ||
| Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. | Q47359822 | ||
| Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice | Q48124495 | ||
| Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures | Q48973809 | ||
| Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). | Q54038662 | ||
| Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome. | Q54577588 | ||
| Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease | Q57605907 | ||
| Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window | Q71289958 | ||
| Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond | Q71652664 | ||
| Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3) | Q73013565 | ||
| Matrix Metalloproteinase-3 Genotype Contributes to Age-Related Aortic Stiffening Through Modulation of Gene and Protein Expression | Q73400898 | ||
| Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage | Q74485860 | ||
| Proinflammatory genetic profiles in subjects with history of ischemic stroke | Q80446078 | ||
| Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study | Q80828049 | ||
| P433 | issue | 1 | |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 130-137 | |
| P577 | publication date | 2008-03-14 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke | |
| P478 | volume | 201 |
| Q34891053 | Are Hill's criteria for causality satisfied for vitamin D and periodontal disease? |
| Q52672943 | Association between matrix metalloproteinase 9 C-1562T polymorphism and the risk of coronary artery disease: an update systematic review and meta-analysis. |
| Q35158307 | Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis |
| Q36261991 | Association between matrix metalloproteinase gene polymorphisms and development of ischemic stroke |
| Q35205043 | Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis |
| Q35709244 | Association of Matrix Metalloproteinase 9 C-1562T Polymorphism with Genetic Susceptibility to Myocardial Infarction: A Meta-Analysis |
| Q64107365 | Association of the MMP-9 polymorphism and ischemic stroke risk in southern Chinese Han population |
| Q49990739 | Association of the genetic and traditional risk factors of ischaemic heart disease with STEMI and NSTEMI development |
| Q57211205 | Cerebral Autoregulation in Hypertension and Ischemic Stroke: A Mini Review |
| Q36160106 | Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia |
| Q64054962 | Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K/Akt signaling pathway |
| Q26775633 | Genetics of ischaemic stroke in young adults |
| Q37728034 | Genetics of stroke |
| Q41997075 | Gut Microbiota and IL-17A: Physiological and Pathological Responses |
| Q35567319 | Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers |
| Q35126269 | Integrative computational and experimental approaches to establish a post-myocardial infarction knowledge map. |
| Q34565352 | Lack of association between a functional variant of the BRCA-1 related associated protein (BRAP) gene and ischemic stroke |
| Q36275092 | Matrix Metalloproteinase-9 (MMP-9) Gene Polymorphism in Stroke Patients. |
| Q44810259 | Meta-analysis of MMP9-562C/T and the risk of coronary heart disease |
| Q37523384 | Myocardial Infarction Superimposed on Aging: MMP-9 Deletion Promotes M2 Macrophage Polarization. |
| Q84514418 | No evidence for an association between genetic variation at the MMP2 and MMP9 loci and aneurysmal subarachnoid haemorrhage |
| Q38931282 | Polymorphisms in IL-10 and INF-γ genes are associated with early atherosclerosis in coronary but not in carotid arteries: A study of 122 autopsy cases of young adults |
| Q33658683 | Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women |
| Q92617676 | Relationship between the matrix metalloproteinase-9 gene polymorphisms and ischemic stroke |
| Q48635397 | Tetramethylpyrazine-2'-O-sodium ferulate attenuates blood-brain barrier disruption and brain oedema after cerebral ischemia/reperfusion |
| Q36763519 | The Correlation between High-Sensitivity C-Reactive Protein, Matrix Metallopeptidase 9, and Traditional Chinese Medicine Syndrome in Patients with Hypertension |
| Q47116540 | The Profile of MMP-9, MMP-9 mRNA Expression, -1562 C/T Polymorphism and Outcome in High-risk Traumatic Brain Injury: The Effect of Therapeutic Mild Hypothermia |
| Q26741200 | The Role of Matrix Metalloproteinase Polymorphisms in Ischemic Stroke |
Search more.